These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 6435751)
1. Essential medicines in the Third World. D'Arcy PF Br Med J (Clin Res Ed); 1984 Oct; 289(6450):982-4. PubMed ID: 6435751 [No Abstract] [Full Text] [Related]
2. The economics of essential drug programmes. Smith GT Soc Sci Med; 1987; 25(6):621-4. PubMed ID: 3686096 [TBL] [Abstract][Full Text] [Related]
3. From the World Health Organization. Essential medicines: 25 years of better health. JAMA; 2002 Dec; 288(24):3102. PubMed ID: 12495381 [No Abstract] [Full Text] [Related]
4. Economics of essential drugs schemes: the perspectives of the developing countries. Wang'ombe JK; Mwabu GM Soc Sci Med; 1987; 25(6):625-30. PubMed ID: 3686097 [TBL] [Abstract][Full Text] [Related]
5. The concept of essential medicines: lessons for rich countries. Hogerzeil HV BMJ; 2004 Nov; 329(7475):1169-72. PubMed ID: 15539676 [TBL] [Abstract][Full Text] [Related]
6. Essential drug lists and health relief management. Simmonds S; Mamdani M Trop Doct; 1988 Oct; 18(4):155-8. PubMed ID: 3194945 [No Abstract] [Full Text] [Related]
7. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Twenty-fourth report. World Health Organ Tech Rep Ser; 1972; 487():1-86. PubMed ID: 4623961 [No Abstract] [Full Text] [Related]
8. Drug control: a prerequisite for health. Yudkin JS Proc R Soc Lond B Biol Sci; 1980 Jul; 209(1174):159-63. PubMed ID: 6106937 [TBL] [Abstract][Full Text] [Related]
9. [Infusion center of the Gera District]. Wilhelm A Pharm Prax; 1970; 3():52-3. PubMed ID: 5430536 [No Abstract] [Full Text] [Related]
10. Incidence of substandard drugs in developing countries. Afu S Trop Med Int Health; 1999 Jan; 4(1):73. PubMed ID: 10203177 [No Abstract] [Full Text] [Related]
11. Drug policy in the Third World. Islam MS Lancet; 1985 Jul; 2(8445):46-7. PubMed ID: 2861497 [No Abstract] [Full Text] [Related]
12. Use caution when donating drugs, guidelines suggest. Riggs B CMAJ; 1990 Jan; 142(1):65-6. PubMed ID: 2293855 [No Abstract] [Full Text] [Related]
13. Spurious and counterfeit drugs: a growing industry in the developing world. Gautam CS; Utreja A; Singal GL Postgrad Med J; 2009 May; 85(1003):251-6. PubMed ID: 19520877 [TBL] [Abstract][Full Text] [Related]
15. US changes trade policy on essential medicines. Yamey G BMJ; 1999 Dec; 319(7224):1521. PubMed ID: 10591704 [No Abstract] [Full Text] [Related]
16. Drugs policy in the Third World. Islam N Lancet; 1985 May; 1(8436):1044. PubMed ID: 2859488 [No Abstract] [Full Text] [Related]
17. Pharmaceuticals for developing countries: an interface of science, technology, and public policy. Simon HJ Pharos Alpha Omega Alpha Honor Med Soc; 1981; 44(2):9-15. PubMed ID: 12085902 [No Abstract] [Full Text] [Related]
18. Provision of medicines in a developing country. Yudkin JS Lancet; 1978 Apr; 1(8068):810-2. PubMed ID: 85826 [TBL] [Abstract][Full Text] [Related]
19. [On misery coast. Episode 1: the market of vital drugs]. Chneiweiss H Med Sci (Paris); 2003; 19(8-9):892-4. PubMed ID: 14593623 [No Abstract] [Full Text] [Related]
20. Comprehensive taxonomy and worldwide trends in pharmaceutical policies in relation to country income status. Maniadakis N; Kourlaba G; Shen J; Holtorf A BMC Health Serv Res; 2017 May; 17(1):371. PubMed ID: 28545440 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]